Eagle Pharmaceuticals Inc (EGRX) Company Profile & Statistics

Eagle Pharmaceuticals Inc
EGRX
(Nasdaq - US)
N/A
4.18
-0.06 (-1.42%)
in:usd•As of: Apr 26, 2024 15:59 UTC -4
Open
4.10
High
4.18
Low
4.07

About Eagle Pharmaceuticals Inc

CEO

Scott Tarriff

Headquarters

50 tice boulevard, suite 315

woodcliff lake, nj 07677, united states

Auditor

Ernst & Young, LLP

Employees

134

Share Holders

Website

www.eagleus.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.

Eagle Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	54.30M
Enterprise Value	109.14M
Enterprise Value/EBITDA (ttm)	1.70
Price to Earnings Ratio (ttm)	3.86
Price to Book (mrq)	0.24
Price to Sales (ttm)	0.23
Price to Cash (ytd)	1.20

Profitability

Gross Margin (ttm)	69.80%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	4.82%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	3.55%
Return on Assets (ttm)	N/A

Income Statement

Revenue (ttm)	257.55M
Revenue Per Share (ttm)	19.83
Gross Profit (ttm)	179.88M
EBITDA (ttm)³	64.06M
Net Income Avi to Common (ttm)	11.95M
Diluted EPS (ttm)	1.18

Share Statistics

Beta (5Y Monthly)	0.41
52-Week Change	-84.90%
S&P500 52-Week Change	25.74%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	12.99M
Dividend Yield	0.00%
Float ⁴	9.23M
% Held by Insiders	28.90%
% Held by Institutions	85.36%

Balance Sheet

Total Cash (mrq)	15.35M
Total Cash Per Share (mrq)	1.18
Total Debt (mrq)	70.19M
Total Debt/Equity (mrq)	27.85%
Current Ratio (mrq)	2.16%
Quick Ratio (mrq)	N/A
Book Value Per Share (mrq)	19.25

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.56
Free Cash Flow (ytd)	-33.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Eagle Pharmaceuticals Inc

Trade With A Regulated Broker